GILEAD SCIENCES INC
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
GILD$170.87+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
| (in millions, except per share amounts) · Gilead Stockholders' Equity · NoncontrollingInterest · TotalStockholders' Equity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-InCapital · Accumulated Other Comprehensive Income · RetainedEarnings | |||||||||||||
| Shares · Amount | |||||||||||||
| Balance as of December 31, 2024 | 1,246 | $1 | $7,700 | $132 | $11,497 | $(84) | $19,246 | ||||||
| Net income | — | — | — | — | 1,315 | — | 1,315 | ||||||
| Other comprehensive loss, net | — | — | — | (40) | — | — | (40) | ||||||
| Issuances under employee stock purchase plan | 1 | — | 82 | — | — | — | 82 | ||||||
| Issuances under equity incentive plans | 7 | — | 175 | — | — | — | 175 | ||||||
| Stock-based compensation | — | — | 211 | — | — | — | 211 | ||||||
| Repurchases of common stock under repurchase programs ($102.46 average price per share) | (7) | — | (29) | — | (701) | — | (730) | ||||||
| Repurchases of common stock for employee tax withholding under equity incentive plans and other | (2) | — | — | — | (176) | — | (176) | ||||||
| Dividends declared ($0.79 per share) | — | — | — | (1,004) | — | (1,004) | |||||||
| Balance as of March 31, 2025 | 1,245 | $1 | $8,138 | $92 | $10,931 | $(84) | $19,078 | ||||||
| (in millions, except per share amounts) · Gilead Stockholders' Equity · NoncontrollingInterest · TotalStockholders' Equity | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-InCapital · Accumulated Other Comprehensive Income · RetainedEarnings | |||||||
| Shares · Amount | |||||||
| Balance as of December 31, 2023 | 1,246 | $1 | $6,500 | $28 | $16,304 | $(84) | $22,749 |
| Net loss | — | — | — | — | (4,170) | — | (4,170) |
| Other comprehensive income, net | — | — | — | 41 | — | — | 41 |
| Issuances under employee stock purchase plan | 1 | — | 80 | — | — | — | 80 |
| Issuances under equity incentive plans | 6 | — | 65 | — | — | — | 65 |
| Stock-based compensation | — | — | 188 | — | — | — | 188 |
| Repurchases of common stock under repurchase programs ($76.88 average price per share) | (5) | — | (20) | — | (380) | — | (400) |
| Repurchases of common stock for employee tax withholding under equity incentive plans and other | (2) | — | — | — | (116) | — | (116) |
| Dividends declared ($0.77 per share) | — | — | — | — | (980) | — | (980) |
| Balance as of March 31, 2024 | 1,246 | $1 | $6,813 | $69 | $10,656 | $(84) | $17,455 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.